Post Hoc Analysis of a Randomized, Double-Blind, Prospective Trial Evaluating a CXCR1/2 Inhibitor in New-Onset Type 1 Diabetes: Endo-Metabolic Features at Baseline Identify a Subgroup of Responders.
FRONTIERS IN ENDOCRINOLOGY（2023）
Key words
IL-8,CXCR1,CXCR2,type 1 diabetes mellitus,trial,post hoc analyses
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined